INTRATUMORAL CONCENTRATION AND MOLECULAR PHARMACODYNAMICS OF LAPATINIB IN VIVO IN SPORADIC AND NF2-RELATED VESTIBULAR SCHWANNOMAS

被引:0
|
作者
Karajannis, Matthias [1 ]
Bergner, Amanda [2 ]
Giovannini, Marco [3 ]
Welling, D. Bradley [4 ]
Niparko, John [2 ]
Slattery, William [3 ]
Roland, J. Thomas [1 ]
Golfinos, John [1 ]
Allen, Jeffrey [1 ]
Blakeley, Jaishri [2 ]
机构
[1] NYU Langone Med Ctr, New York, NY USA
[2] Johns Hopkins Univ, Baltimore, MD USA
[3] House Ear Res Inst, Los Angeles, CA 90034 USA
[4] Ohio State Univ, Columbus, OH 43210 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:19 / 19
页数:1
相关论文
共 50 条
  • [41] Differential NF2 Gene Status in Sporadic Vestibular Schwannomas and its Prognostic Impact on Tumour Growth Patterns
    Chen, Hongsai
    Xue, Lu
    Wang, Hantao
    Wang, Zhaoyan
    Wu, Hao
    SCIENTIFIC REPORTS, 2017, 7
  • [42] Differential NF2 Gene Status in Sporadic Vestibular Schwannomas and its Prognostic Impact on Tumour Growth Patterns
    Hongsai Chen
    Lu Xue
    Hantao Wang
    Zhaoyan Wang
    Hao Wu
    Scientific Reports, 7
  • [43] Targeting MERTK on tumour cells and macrophages: a potential intervention for sporadic and NF2-related meningioma and schwannoma tumours
    Dave, Foram
    Herrera, Kevin
    Lockley, Alex
    van de Weijer, Laurien L.
    Henderson, Summer
    Sofela, Agbolahan A.
    Hook, Laura
    Adams, Claire L.
    Ercolano, Emanuela
    Hilton, David A.
    Maze, Emmanuel A.
    Kurian, Kathreena M.
    Ammoun, Sylwia
    Hanemann, C. Oliver
    ONCOGENE, 2024, 43 (41) : 3049 - 3061
  • [44] Analysis of tumor microenvironment composition in vestibular schwannomas: insights into NF2-associated and sporadic variations and their clinical correlations
    Nickl, Vera
    Ziebolz, David
    Rumpel, Charlotte
    Klein, Dennis
    Nickl, Robert
    Rampeltshammer, Eva
    Monoranu, Camelia M.
    Ernestus, Ralf-Ingo
    Matthies, Cordula
    Loehr, Mario
    Hagemann, Carsten
    Breun, Maria
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [45] A cerebellopontine angle mouse model for the investigation of tumor biology, hearing, and neurological function in NF2-related vestibular schwannoma
    Chen, Jie
    Landegger, Lukas D.
    Sun, Yao
    Ren, Jun
    Maimon, Nir
    Wu, Limeng
    Ng, Mei R.
    Chen, John W.
    Zhang, Na
    Zhao, Yingchao
    Gao, Xing
    Fujita, Takeshi
    Roberge, Sylvie
    Huang, Peigen
    Jain, Rakesh K.
    Plotkin, Scott R.
    Stankovic, Konstantina M.
    Xu, Lei
    NATURE PROTOCOLS, 2019, 14 (02) : 541 - 555
  • [46] A cerebellopontine angle mouse model for the investigation of tumor biology, hearing, and neurological function in NF2-related vestibular schwannoma
    Jie Chen
    Lukas D. Landegger
    Yao Sun
    Jun Ren
    Nir Maimon
    Limeng Wu
    Mei R. Ng
    John W. Chen
    Na Zhang
    Yingchao Zhao
    Xing Gao
    Takeshi Fujita
    Sylvie Roberge
    Peigen Huang
    Rakesh K. Jain
    Scott R Plotkin
    Konstantina M. Stankovic
    Lei Xu
    Nature Protocols, 2019, 14 : 541 - 555
  • [47] Multicenter, prospective, phase II study of maintenance bevacizumab for children and adults with NF2-related schwannomatosis and progressive vestibular schwannoma
    Plotkin, Scott R.
    Allen, Jeffrey
    Dhall, Girish
    Campian, Jian L.
    Clapp, D. Wade
    Fisher, Michael J.
    Jain, Rakesh K.
    Tonsgard, James
    Ullrich, Nicole J.
    Thomas, Coretta
    Edwards, Lloyd J.
    Korf, Bruce
    Packer, Roger
    Karajannis, Matthias A.
    Blakeley, Jaishri O.
    NEURO-ONCOLOGY, 2023, 25 (08) : 1498 - 1506
  • [48] INTUITT-NF2, AN ADAPTIVE PLATFORM-BASKET TRIAL FOR NF2-RELATED SCHWANNOMATOSIS PATIENTS WITH PROGRESSIVE SCHWANNOMAS, MENINGIOMAS, AND EPENDYMOMAS: PRIMARY OUTCOME OF THE BRIGATINIB TREATMENT ARM
    Plotkin, Scott R.
    Babovic-Vuksanovic, Dusica
    Dinh, Christine
    Fell, Geoffrey
    Merker, Vanessa
    Nghiemphu, Phioanh
    Trippa, Lorenzo
    Yohay, Kaley
    Blakeley, Jaishri
    NEURO-ONCOLOGY, 2023, 25
  • [49] Bevacizumab in Neurofibromatosis type 2 (NF2) related vestibular schwannomas: a nationally coordinated approach to delivery and prospective evaluation
    Morris, Katrina A.
    Golding, John F.
    Axon, Patrick R.
    Afridi, Shazia
    Blesing, Claire
    Ferner, Rosalie E.
    Halliday, Dorothy
    Jena, Raj
    Pretorius, Pieter M.
    Evans, D. Gareth
    McCabe, Martin G.
    Parry, Allyson
    NEURO-ONCOLOGY PRACTICE, 2016, 3 (04) : 281 - 289
  • [50] THE MAYO CLINIC MULTIDISCIPLINARY NF2 CLINIC EXPERIENCE OF BEVACIZUMAB IN NEUROFIBROMATOSIS TYPE 2-RELATED SCHWANNOMATOSIS PATIENTS WITH VESTIBULAR SCHWANNOMAS
    Webb, M. J.
    Webb, L. M.
    Van Gompel, J. J.
    Link, M. J.
    Neff, B. A.
    Carlson, M. L.
    Driscoll, C. W.
    Ruff, M. W.
    Anderson, K. A.
    Neth, B. J.
    Kizilbash, S. H.
    Uhm, J. H.
    Lane, J. I.
    Benson, J. C.
    Blezek, D. J.
    Mehta, P. M.
    Bathla, G.
    Sener, U. T.
    NEURO-ONCOLOGY, 2023, 25